Issued Patents All Time
Showing 1–25 of 59 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12318434 | Alkaline phosphate-based oncology treatments | Christian FURLAN FREGUIA | 2025-06-03 |
| 12274740 | Microbiome protection from oral antibiotics | Sheila Connelly | 2025-04-15 |
| 12178917 | Beta-lactamase formulations and uses thereof | Andrew Bristol, Sheila Connelly | 2024-12-31 |
| 12048735 | Alkaline phosphatase formulations | Vincent John Wacher, J. Blair WEST, Christian FURLAN FREGUIA | 2024-07-30 |
| 11981899 | E. coli-based production of beta-lactamase | Andrew Bristol, Steven Hubert | 2024-05-14 |
| 11944669 | Method and compositions for inhibiting or preventing adverse effects of oral antibiotics | Sheila Connelly, Vincent John Wacher | 2024-04-02 |
| 11883474 | Microbiome protection from oral antibiotics | Sheila Connelly | 2024-01-30 |
| 11654184 | Alkaline phosphatase agents for treatment of radiation disorders | Christian FURLAN FREGUIA, Sheila Connelly | 2023-05-23 |
| 11638699 | Intestinal alkaline phosphatase formulations | Andrew Bristol, Ray STAPLETON, Christian FURLAN FREGUIA, Steven Hubert, Cristina FREIRE +1 more | 2023-05-02 |
| 11608494 | Beta-lactamases with improved properties for therapy | Sheila Connelly | 2023-03-21 |
| 11596674 | Method and compositions for inhibiting or preventing adverse effects of oral antibiotics | Sheila Connelly, Vincent John Wacher | 2023-03-07 |
| 11542510 | E. coli-based production of beta-lactamase | Andrew Bristol, Steven Hubert | 2023-01-03 |
| 11517614 | Microbiome protection from oral antibiotics | Sheila Connelly | 2022-12-06 |
| 11338020 | Alkaline phosphatase agents for treatment of neurodevelopmental disorders | Christian FURLAN FREGUIA, Sheila Connelly | 2022-05-24 |
| 11236319 | Beta-lactamases with improved properties for therapy | Sheila Connelly | 2022-02-01 |
| 11123413 | Carbapenemases for use with antibiotics for the protection of the intestinal microbiome | Sheila Connelly | 2021-09-21 |
| 11034966 | E. coli-based production of beta-lactamase | Andrew Bristol, Steven Hubert | 2021-06-15 |
| 11001822 | Complement factor B analogs and their uses | ChangHung Chen, Beibei Li, Tianci Luo, Jeffrey Allan Miller, Ruigong Wang | 2021-05-11 |
| 10987410 | Alkaline phosphatase formulations | Vincent John Wacher, J. Blair WEST, Christian FURLAN FREGUIA | 2021-04-27 |
| 10828260 | Beta-lactamase formulations and uses thereof | Andrew Bristol, Sheila Connelly | 2020-11-10 |
| 10792346 | Method and compositions for inhibiting or preventing adverse effects of oral antibiotics | Sheila Connelly, Vincent John Wacher | 2020-10-06 |
| 10767171 | Beta-lactamases with improved properties for therapy | Sheila Connelly | 2020-09-08 |
| 10689637 | Complement factor B analogs and their uses | ChangHung Chen, Beibei Li, Tianci Luo, Jeffrey Allan Miller, Ruigong Wang | 2020-06-23 |
| 10584326 | Beta-lactamases with improved properties for therapy | Sheila Connelly | 2020-03-10 |
| 10548955 | Carbapenemases for use with antibiotics for the protection of the intestinal microbiome | Sheila Connelly | 2020-02-04 |